Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome.

Lynch RM, Mantus G, Encinales L, Pacheco N, Li G, Porras A, Mendoza AR, Peng J, Rengifo-Pardo M, Cruz MM, Harris E, Bethony JM, Simon GL, Chang AY.

J Infect Dis. 2019 Jan 1;219(1):26-30. doi: 10.1093/infdis/jiy466.

2.

A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia.

Anaya JM, Rodríguez Y, Monsalve DM, Vega D, Ojeda E, González-Bravo D, Rodríguez-Jiménez M, Pinto-Díaz CA, Chaparro P, Gunturiz ML, Ansari AA, Gershwin ME, Molano-González N, Ramírez-Santana C, Acosta-Ampudia Y.

J Autoimmun. 2017 Feb;77:123-138. doi: 10.1016/j.jaut.2016.12.007. Epub 2017 Jan 3.

3.

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.

Swanstrom JA, Plante JA, Plante KS, Young EF, McGowan E, Gallichotte EN, Widman DG, Heise MT, de Silva AM, Baric RS.

MBio. 2016 Jul 19;7(4). pii: e01123-16. doi: 10.1128/mBio.01123-16.

4.

The 2016 Singapore Zika virus outbreak did not cause a surge in Guillain-Barré syndrome.

Umapathi T, Kam YW, Ohnmar O, Ng BCJ, Ng Y, Premikha M, Leo YS, Ng LFP.

J Peripher Nerv Syst. 2018 Sep;23(3):197-201. doi: 10.1111/jns.12284. Epub 2018 Aug 21.

PMID:
30070025
5.

Clinical and nerve conduction features in Guillain-Barré syndrome associated with Zika virus infection in Cúcuta, Colombia.

Uncini A, González-Bravo DC, Acosta-Ampudia YY, Ojeda EC, Rodríguez Y, Monsalve DM, Ramírez-Santana C, Vega DA, Paipilla D, Torres L, Molano-González N, Osorio JE, Anaya JM.

Eur J Neurol. 2018 Apr;25(4):644-650. doi: 10.1111/ene.13552. Epub 2018 Feb 6.

PMID:
29266602
6.

Zika virus and Guillain-Barré syndrome in Bangladesh.

GeurtsvanKessel CH, Islam Z, Islam MB, Kamga S, Papri N, van de Vijver DAMC, Reusken C, Mogling R, Heikema AP, Jahan I, Pradel FK, Pavlicek RL, Mohammad QD, Koopmans MPG, Jacobs BC, Endtz HP.

Ann Clin Transl Neurol. 2018 Apr 6;5(5):606-615. doi: 10.1002/acn3.556. eCollection 2018 May.

7.

Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia.

Parra B, Lizarazo J, Jiménez-Arango JA, Zea-Vera AF, González-Manrique G, Vargas J, Angarita JA, Zuñiga G, Lopez-Gonzalez R, Beltran CL, Rizcala KH, Morales MT, Pacheco O, Ospina ML, Kumar A, Cornblath DR, Muñoz LS, Osorio L, Barreras P, Pardo CA.

N Engl J Med. 2016 Oct 20;375(16):1513-1523. Epub 2016 Oct 5.

8.

Flavivirus cross-reactivity in serological tests and Guillain-Barré syndrome in a hematopoietic stem cell transplant patient: A case report.

Raboni SM, Bonfim C, Almeida BM, Zanluca C, Koishi AC, Rodrigues PRVP, Kay CK, Ribeiro LL, Scola RH, Duarte Dos Santos CN.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12700. Epub 2017 Jul 3.

PMID:
28306183
9.

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.

Delgado FG, Torres KI, Castellanos JE, Romero-Sánchez C, Simon-Lorière E, Sakuntabhai A, Roth C.

Viruses. 2018 Sep 7;10(9). pii: E480. doi: 10.3390/v10090480.

10.

Guillain-Barré syndrome in patients with a recent history of Zika in Cúcuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016.

Arias A, Torres-Tobar L, Hernández G, Paipilla D, Palacios E, Torres Y, Duran J, Ugarte U S, Ardila-Sierra A, Castellanos G.

J Crit Care. 2017 Feb;37:19-23. doi: 10.1016/j.jcrc.2016.08.016. Epub 2016 Aug 18.

PMID:
27610587
11.

Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.

Masel J, McCracken MK, Gleeson T, Morrison B, Rutherford G, Imrie A, Jarman RG, Koren M, Pollett S.

PLoS Negl Trop Dis. 2019 Jan 25;13(1):e0007060. doi: 10.1371/journal.pntd.0007060. eCollection 2019 Jan.

12.

Coordination of different ligands to copper(II) and cobalt(III) metal centers enhances Zika virus and dengue virus loads in both arthropod cells and human keratinocytes.

Dutta S, Celestine MJ, Khanal S, Huddleston A, Simms C, Arca JF, Mitra A, Heller L, Kraj PJ, Ledizet M, Anderson JF, Neelakanta G, Holder AA, Sultana H.

Biochim Biophys Acta Gen Subj. 2018 Jan;1862(1):40-50. doi: 10.1016/j.bbagen.2017.10.004. Epub 2017 Oct 13.

PMID:
29030319
13.

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.

Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, Sakuntabhai A, Cao-Lormeau VM, Malasit P, Rey FA, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2016 Sep;17(9):1102-8. doi: 10.1038/ni.3515. Epub 2016 Jun 23.

14.

Concurrent Guillain-Barré syndrome, transverse myelitis and encephalitis post-Zika: A case report and review of the pathogenic role of multiple arboviral immunity.

Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, Anaya JM.

J Neurol Sci. 2018 Dec 15;395:47-53. doi: 10.1016/j.jns.2018.09.028. Epub 2018 Sep 26. Review. Erratum in: J Neurol Sci. 2018 Dec 15;395:207-209.

15.

Guillain-Barré Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study.

Rozé B, Najioullah F, Fergé JL, Dorléans F, Apetse K, Barnay JL, Daudens-Vaysse E, Brouste Y, Césaire R, Fagour L, Valentino R, Ledrans M, Mehdaoui H, Abel S, Leparc-Goffart I, Signate A, Cabié A; Guillain-Barré Syndrome Zika Working Group of Martinique.

Clin Infect Dis. 2017 Oct 16;65(9):1462-1468. doi: 10.1093/cid/cix588.

PMID:
29020245
16.

Zika virus disease-associated Guillain-Barré syndrome-Barranquilla, Colombia 2015-2016.

Salinas JL, Walteros DM, Styczynski A, Garzón F, Quijada H, Bravo E, Chaparro P, Madero J, Acosta-Reyes J, Ledermann J, Arteta Z, Borland E, Burns P, Gonzalez M, Powers AM, Mercado M, Solano A, Sejvar JJ, Ospina ML.

J Neurol Sci. 2017 Oct 15;381:272-277. doi: 10.1016/j.jns.2017.09.001. Epub 2017 Sep 4.

PMID:
28991697
17.

Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.

Castanha PMS, Souza WV, Braga C, Araújo TVB, Ximenes RAA, Albuquerque MFPM, Montarroyos UR, Miranda-Filho DB, Cordeiro MT, Dhalia R, Marques ETA Jr, Rodrigues LC, Martelli CMT; Microcephaly Epidemic Research Group.

PLoS Negl Trop Dis. 2019 Mar 11;13(3):e0007246. doi: 10.1371/journal.pntd.0007246. eCollection 2019 Mar.

18.

Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.

Calvert AE, Boroughs KL, Laven J, Stovall JL, Luy BE, Kosoy OI, Huang CY.

J Clin Microbiol. 2018 May 25;56(6). pii: e00234-18. doi: 10.1128/JCM.00234-18. Print 2018 Jun.

19.

Zika virus infection and risk of Guillain-Barré syndrome: A meta-analysis.

Bautista LE.

J Neurol Sci. 2019 Jun 21;403:99-105. doi: 10.1016/j.jns.2019.06.019. [Epub ahead of print]

PMID:
31255970
20.

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.

Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith ARY, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, Diamond MS, Ledgerwood JE, Pierson TC.

Cell Rep. 2016 Aug 9;16(6):1485-1491. doi: 10.1016/j.celrep.2016.07.049. Epub 2016 Jul 29.

Supplemental Content

Support Center